Drug Design for Cerebral Ischemia: A Molecular Perspective Review

Area of Science:

• Neurology
• Pharmacology
• Biochemistry

Background:

• Ischemic stroke results from interrupted blood flow, causing brain tissue damage and neurological deficits.
• Reperfusion can exacerbate injury via oxidative stress, inflammation, and blood-brain barrier issues.
• Existing treatments for ischemic stroke are insufficient, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

• To review and evaluate potential drug candidates for cerebral ischemia.
• To identify compounds with neuroprotective, antioxidant, anti-inflammatory, and anti-ferroptotic properties.

Main Methods:

• Comprehensive literature search for drug candidates targeting cerebral ischemia.
• Analysis of 271 compounds based on core structures (e.g., triazole, piperazine) and functional groups (e.g., hydroxyl, halogen).

Main Results:

• Identified numerous compounds exhibiting promising neuroprotective effects.
• Compounds with triazole, piperazine, pyrrole, amide, pyridine, and oxadiazole cores showed significant potential.
• Key functional groups contributing to efficacy include hydroxyl, halogen, and alkyl groups.

Conclusions:

• Several drug candidates demonstrate significant potential for treating ischemic stroke.
• Further research and optimization are needed to develop effective therapies for ischemic brain injury.
• These findings may lead to reduced mortality and disability from stroke.